ClinicalTrials.gg
RecruitingNCT06815302Updated Jul 28, 2025

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

An interventional study of Experimental intervention and Active intervention in Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease, sponsored by Oregon Health and Science University. Recruiting at 3 sites in 2 countries. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-28.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Parkinson Disease by Oregon Health and Science University — 4 open to participants now, 4 under way, none of them phase 3. Parkinson Disease · Oregon Health and Science University.

Planned enrollment
7th of 28
60 · median 22
Started
2025
with 1 other
No phase
17 of 36
4 open now
Registered
36th of 36
by date

Among the 36 studies in Parkinson Disease by Oregon Health and Science University, this one is the 7th largest by planned enrollment of the 28 interventional ones that give a count, is one of 2 that started in 2025, is one of 17 with no phase, and was the 36th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

4 of the 36 studies in Parkinson Disease by Oregon Health and Science University are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 50 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Parkinson Disease by Oregon Health and Science University, or all of them as a file.
02

Study summary

The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial.

Participants will:

  • Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise)
  • Have one-on-one training sessions three times per week for 6 weeks
  • Perform in-lab assessments before beginning and after completing the study intervention
  • Use wearable mobility sensors during daily life to measure their walking and balance
03

Conditions studied

  • Parkinson Disease
  • Freezing of Gait Symptoms in Parkinson Disease

Browse trials for

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with one or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
  • reporting FOG in the New Freezing of Gait questionnaire (N-FOGQ)
  • Hoehn \& Yahr stages II-IV
  • ages 50-80 years old
  • cognitive ability sufficient to participate in testing procedures and exercise classes
  • be willing and able to participate in exercise intervention 3x/week for 6 weeks

Exclusion criteria

Exclusion Criteria:

  • Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and turning (i.e., musculoskeletal disorder, vestibular problem, head injury, stroke, cardiac disease)
  • medical condition or medications that precludes moderate-intensity exercise
  • (MoCA) ≤21 or inability to follow directions
  • excessive use of alcohol or recreational drugs
  • recent change in medication
  • inability to stand and walk for 2 minutes without an assistive device
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Dynamic balance exercise intervention group

    Six weeks of exercise intervention to improve gait disturbances. Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.

    Behavioral: Experimental intervention

  • Active comparator
    Strength training exercise intervention group

    Six weeks of exercise intervention to improve gait disturbances. Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.

    Behavioral: Active intervention

Interventions

  • BehavioralExperimental intervention

    Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.

  • BehavioralActive intervention

    Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.

06

What researchers measure

Primary outcomes

  1. Patient- Perceived Freezing of Gait Severity

    Change in freezing of gait severity with the intervention (scored in likert scale by the patient; 3 = Much improved, 2 = Somewhat improved, 1 = Minimally improved, 0 = No change, -1 = Minimally worse, -2 = Somewhat worse, -3 = Much worse)

    Time frame: From enrollment/randomization through intervention; 8 weeks

  2. Clinician- Perceived Freezing of Gait Severity

    Change in freezing of gait severity with the intervention (scored in likert scale by the clinician; 3 = Much improved, 2 = Somewhat improved, 1 = Minimally improved, 0 = No change, -1 = Minimally worse, -2 = Somewhat worse, -3 = Much worse

    Time frame: From enrollment/randomization through intervention; 8 weeks

  3. Sensors-based Freezing of gait severity

    Freezing of Gait Index calculated during a 360 degrees turning in place from wearable sensors; continuous scale, with a higher positive score meaning a greater level of freezing of gait.

    Time frame: From enrollment/randomization through intervention; 8 weeks

Secondary outcomes

  1. Time Spent in FOG during daily life

    % time spent FOG compared to walking during daily life calculated from wearable sensors

    Time frame: From enrollment/randomization through intervention; 8 weeks

07

Study locations

3 of 3 sites recruiting
  • Arizona State University
    Tempe, Arizona 85281, United States
    Recruiting
  • Oregon Health and Science University
    Portland, Oregon 97239, United States
    Recruiting
  • University of São Paulo, Bauru Campus
    Bauru, São Paulo 17012-230, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data related to study outcomes measures will be publicly shared

Time frame: Data would be available 6 months after publication.

Access criteria: Data will be deposited on Zenodo https://zenodo.org/records/12548174

Data sharing details ↗ · zenodo.org

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 18 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 7, 2025
StartActual
Jun 2, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jun 30, 2027
Last update
Jul 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06815302
Collaborators
Michael J. Fox Foundation for Parkinson's Research
Responsible party
Martina Mancini (Associate Professor, Oregon Health and Science University) — Principal investigator
First posted
Feb 7, 2025
Start date
Jun 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jul 28, 2025

Study contacts

Graham R Harker, MPH
Contact
harkerg@ohsu.edu
(503) 418-2601
Martina Mancini, PhD
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion